ZN-c5

N/A

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameZN-c5
Drug Alias NameZN-c5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors degraders
TargetsEstrogen receptors
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBosnia and HerzegovinaUnited States +[13] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZeno Alpha Inc
China Registration ClassN/A

Develop Information

Active CompaniesZeno Alpha IncZhengtengkang Biotechnology (Shanghai) Co LtdZentera Therapeutics HK Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A